9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Extracellular ATP and cAMP as Paracrine and Interorgan Regulators of Renal Function Renal Microvascular Effects of P2 Receptor Stimulation

      Clinical and Experimental Pharmacology and Physiology
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: not found
          • Article: not found

          Purinoceptors: Are there families of P2X and P2Y purinoceptors?

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adenosine A3 receptors: novel ligands and paradoxical effects.

            The physiological role of the adenosine A3 receptor is being investigated using newly synthesized, selective ligands. Recently, in addition to agonists, selective antagonists have been developed that belong to three distinct, non-purine chemical classes: flavonoids, 1,4-dihydropyridine derivatives (e.g. MRS1191, which is 1300-fold selective for human adenosine A3 vs A1/A2A receptors, with a Ki value of 31 nM) and the triazoloquinazolines (e.g. MRS1220, which has a Ki value of 0.65 nM). The A3 receptor has proven enigmatic in terms of antagonist ligand specificity, coupling to second messengers, and biological effects in the CNS, inflammatory system and cardiovascular system. A3 receptors are also potentially involved in apoptosis. It appears that intense, acute activation of A3 receptors acts as a lethal input to cells, while low concentrations of A3 receptor agonists protect against apoptosis. Here, Kenneth Jacobson describes how A3 receptor agonists might be useful in treating inflammatory conditions, possibly through their inhibition of tumour necrosis factor alpha (TNF-alpha) release, which has been shown in macrophages. A3 receptor antagonists might be useful in treating asthma or acute brain ischaemia. Recently, the versatility of A3 receptor agonists, administered either before or during ischaemia, in eliciting potent cardioprotection has been shown.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Increased release of ATP from endothelial cells during acute inflammation.

              The effects of lipopolysaccharide (LPS), a potent inflammatory mediator, on the shear stress stimulated release of adenosine triphosphate (ATP) were investigated on endothelial cells from human umbilical vein in primary culture. Human umbilical vein endothelial cells (HUVEC) in primary cultures were subjected to shear stress using a cone and plate apparatus. ATP released by the cells was measured by luminometry, using a luciferin-luciferase assay. Under conditions of shear stress alone (25dyn/cm2), ATP accumulates into the culture medium and reaches a maximum after 3 to 5 min of stimulation (121.7+/-13.2 pmol/ml). The shear stress-stimulated release of ATP was significantly increased after a 4 h pre-incubation of endothelial cells with 50 microg/ml (314.4+/-26.7 pmol/ml) and 10microg/ml lipopolysaccharide (207.7+/-22.2 pmol/ml). Dexamethasone, an anti-inflammatory glucocorticoid, inhibited the effects of lipopolysaccharide. These results show that non-damaged endothelial cells release ATP under experimental inflammatory conditions and support an early role of extracellular ATP in the inflammatory process.
                Bookmark

                Author and article information

                Journal
                Clinical and Experimental Pharmacology and Physiology
                Clin Exp Pharmacol Physiol
                Wiley
                0305-1870
                1440-1681
                April 2001
                April 2001
                : 28
                : 4
                : 332-339
                Article
                10.1046/j.1440-1681.2001.03450.x
                9e628c7f-4c55-41ad-b6da-d2cb73cf9552
                © 2001

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article